YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Injured by Meridia?
Meridia (generic: sibutramine hci monohydrate) has been linked to side effects such as rapid heart rate, increased blood pressure, heart disease, stroke, seizure and mental impairments. Meridia is a drug that is used to treat obesity by controlling appetite.Italy has suspended the sale of weight-loss products containing sibutramine, marketed as Meridia in the U.S. by Abbott Laboratories. Italy's Health Ministry said on March 7, 2002 that it was immediately withdrawing all sibutramine products from the market due to 50 reports of health-related problems. Although Italy was the first country to take the drugs off the market, other nations' regulatory bodies have expressed concern about sibutramine. Britain's Drug and Therapeutics Bulletin, published by the Consumers' Association, warned that the weight-loss drug had limited benefits and unwanted side effects.
In addition to the risk of cardiovasular problems, seizures, and mental impairments, it is believed that two women have died as a result of complications from the drug. Abbott Laboratories estimates that 8.6 million people have used sibutramine-based drugs since they were approved in 1997.
If you or a loved one took Meridia and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.
MeridiaRSS Feed
Merida Faces European Ban
Jan 22, 2010 | Parker Waichman Alonso LLP
The same day U.S. health regulators warned that Meridia (sibutramine) shouldn’t be given to patients with a history of heart problems, their counterparts in Europe said the popular diet drug should be banned. The European Medicines Agency said that sibutramine – sold in Europe under several names, including Reductil, Reduxade and Zelium – should be pulled from the market because of associated risks of stroke and heart attack. The call for a European ban came after a study of...
Meridia Label Changes Announced
Jan 21, 2010 | Parker Waichman Alonso LLP
The U.S. Food & Drug Administration (FDA) today informed healthcare professionals that it had requested and Abbot Laboratories has agreed to add a new contraindication to the label of the weight loss drug, Meridia. The contraindication will state that Meridia is not to be used in patients with a history of cardiovascular disease, including: • History of coronary artery disease (e.g., heart attack, angina) • History of stroke or transient ischemic attack (TIA) • History of...
Meridia Faces European Scrutiny
Dec 21, 2009 | Parker Waichman Alonso LLP
Sibutramine, the prescription diet drug sold in the U.S. as Meridia, is being reviewed in Europe because it may be associated with an increased risk of heart attack and stroke. In a press release issued December 18, the European Medicines Agency (EMEA) said it is reviewing data from a study known as SCOUT (Sibutramine Cardiovascular Morbidity/Mortality Outcomes in Overweight or Obese Subjects at Risk of a Cardiovascular Event) that indicate an increased risk of serious...
Ban Meridia Now, Public Citizen Says
Dec 4, 2009 | Parker Waichman Alonso LLP
Meridia, a weight loss drug marketed by Abbot Laboratories, should be banned by the U.S. Food & Drug Administration (FDA) immediately, according to the consumer advocacy group Public Citizen. In a press release announcing that it has filed its second petition with the FDA to have Meridia banned, Public Citizen said the drug has caused a significantly increased number of heart attacks, strokes, resuscitated cardiac arrests or deaths in obese patients.Meridia (sibutramine) was approved...
Meridia May Raise Risk of Heart Attacks, Strokes and Death, FDA Says
Nov 23, 2009 | Parker Waichman Alonso LLP
Meridia, Abbott Labs' popular prescription weight loss medication, may be associated with a higher risk of heart-related side-effects, including heart attacks, strokes and death. Over the weekend, the U.S. Food & Drug Administration (FDA) issued a Meridia Early Communication, and said it was reviewing preliminary data from a recent study that indicated patients taking Meridia for weight loss are likelier to suffer such side effects.Meridia (sibutramine) was approved by the FDA...
Meridia
Quick Facts
Meridia Reference Guide
Generic Name
Sibutramine hci monohydrate
Date Approved
November 8, 1996
Manufacturer
Knoll Pharmaceutical
Status
On the market
Approved Uses
Obesity
Serious Side Effects
Rapid heart rate
High blood pressure
Heart disease
Stroke
Seizure
Related Topics
Stroke
Defective Drugs
Diseases
Sibutramine hci monohydrate
Date Approved
November 8, 1996
Manufacturer
Knoll Pharmaceutical
Status
On the market
Approved Uses
Obesity
Serious Side Effects
Rapid heart rate
High blood pressure
Heart disease
Stroke
Seizure
Related Topics
Stroke
Defective Drugs
Diseases
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS